Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-06
1998-09-29
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530380, 530395, A61K 3817, A61K 3818, C07K 1447, C07K 14515
Patent
active
058146024
ABSTRACT:
A heparin-binding protein (HBP) which has, in glycosylated state, an apparent molecular weight of about 28 kDa, determined by SDS-PAGE under reducing conditions, and exhibits angiogenic properties in vivo.
REFERENCES:
patent: 5026639 (1991-06-01), Johnson
patent: 5087569 (1992-02-01), Gabay et al.
patent: 5458874 (1995-10-01), Pereira et al.
patent: 5484885 (1996-01-01), Pereira et al.
Shafer et al., Infection and Immunity, vol. 45, No. 1, pp. 29-35 (1984).
Shafer et al., Infection and Immunity, vol. 53, No. 3, pp. 651-655 (1986).
Dialog Information Services, File 55, BIOSIS 81-89, BIOSIS No. 79028069, Raugi G J et al.: "Location and partial characterization of the heparin-binding fragment of platelet thrombospondin", Thromb Res 36(2), 1984, 165-176.
PCT International Preliminary Examination Report, pp. 1, 1A and 3 and PCT claims 1-17, 1990.
Dialog Information Services, File 55, BIOSIS 81-89, BIOSIS No. 85050038, Rauvala H et al: "Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons", J Biol Chem 262(34), 1987, 16625-16635.
Dialog Information Services, File 55, BIOSIS 81-89, BIOSIS No. 83082612, Pande H et al: Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxyl-terminal heparin-bindnng domain Eur J Biochem 162(2), 1987, 403-412.
Dialog Information Serivces, File 55, BIOSIS 81-89, BIOSIS No. 79028069, Raugi G J et al: "Location and partial characterization of the heparin-binding fragment of platelet thrombospondin", Thromb Res 36(2), 1984, 165-176 . . . / . . .
Sally W. Hennessy, Complete Thrombospindin mRNA Sequence Includes Potential Regulatory Sites in the 3'Untranslated Region pp. 729-735, J. Cell. Biol. vol. 108 (1989).
Eur. J. Biochem., vol. 197, issued 1991, Flodgaard et al, "Covalent Structure of Two Novel Neutrophilin", pp. 535-547.
Lawler et al., Thromb. Res., vol. 22, pp. 267-279 (1981).
Petersen et al., J. Urology, vol. 142, pp. 176-180 (1989).
Pande et al, Eur. J. Biochem. vol. 162 (2) pp. 403-412 (1987).
Rauvala et al., J. Biol. Chem., vol. 262 No. 34 pp. 16625-16635 (1987).
Raugi et al., Thromb. Des., vol. 36 pp. 165-175 (1984).
Chodale et al, Cancer Res., vol. 46 pp. 5507-5510 (1986).
Pereira et al., J. Clin. Invest., vol. 85 pp. 1468-1476 (1990).
Pohl et al., FEBS Lett., vol. 272, No. 1, 2, pp. 200-204 (1990).
Wilde et al., J. Biol. Chem., vol. 265 pp. 2038-2041 (1990).
Gabay et al., PNAS USA, vol. 86 pp. 5610-5614 (1989).
Chodak et al., Cancer Res., vol. 46(11) pp. 5507-5510 (1986).
Neurath et al, "The Proteins", 3.sup.rd ed., published 1975 by Academic Press (NY), vol. I, pp. 179, 180, and 191.
Bayne Stephen
Flodgaard Hans
Ostergaard Erik
Thomsen Johannes
Agris Cheryl H.
Novo Nordisk A S
Russel Jeffrey E.
Zelson Steve T.
LandOfFree
Heparin-binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heparin-binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparin-binding proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686272